Terms and conditions

Devyser terms and conditions

Please find the terms and conditions for different countries and regions below.

Country	Legal terms
Austria	Terms and conditions
Benelux	Terms and conditions
Germany	Terms and conditions
Switzerland	Terms and conditions
United Kingdom	Terms and conditions
Nordics	Terms and conditions
North America	Terms and conditions
Distributor sales	Terms and conditions
France	Terms and conditions

Insight and inspiration

News IVDR | March 1, 2023

We have launched our first IVDR-certified product

Today we launched our first IVDR-certified product. Devyser Compact is a rapid genetic test for prenatal chromosome testing and the first of its type to be approved under the new more comprehensive regulation that came into force in May 2022. The original product was first launched in 2006 and is today the golden standard in prenatal testing in many European countries.

Find out more

Webinar on-demand | February 16, 2023

Post-transplant monitoring: The future of chimerism testing

News | January 25-26, 2023

We are attending the Festival of Genomics & Biodata!

Podcast | December 6, 2022

Collaborations and homebrew assays by Dan Hauzenberger & Turid Sundin Carlsson

Latest from the Devyser blog

View all

NGS identification of both male and female cancer risks

Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...

CRISPR Helps BRCA1 Researchers Determine Functional And Non-Functional Mutations

BRCA1 variants may generally be divided into three categories: benign variants, which cause no...

New Devyser BRCA NGS study published

Check out a recent publication from Capone et al from the University of Florence!

Robust NGS workflow provides full BRCA1 & BRCA2 screening

The team at Devyser were excited to see our products put to use in a recent research project,...